Abstract P4-15-03: An analysis of the National Institutes of Health (NIH) breast cancer research portfolio and the Department of Defense (DOD) breast cancer research program (BCRP) funding for metastatic breast cancer research in fiscal year 2016

Mapping Intimacies ◽

10.1158/1538-7445.sabcs19-p4-15-03 ◽

2020 ◽

Author(s):

Judy Perkins

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Research Program ◽

Department Of Defense ◽

Metastatic Breast ◽

National Institutes Of Health ◽

Breast Cancer Research ◽

Download Full-text

Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study

British Journal of Cancer ◽

10.1038/sj.bjc.6601840 ◽

2004 ◽

Vol 90 (11) ◽

pp. 2131-2134 ◽

Author(s):

A C Humphreys ◽

J Dent ◽

S Rodwell ◽

S M Crawford ◽

J K Joffe ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Venous Infusion

Download Full-text

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

The Lancet Oncology ◽

10.1016/s1470-2045(07)70041-4 ◽

2007 ◽

Vol 8 (3) ◽

pp. 219-225 ◽

Author(s):

Miguel Martín ◽

Amparo Ruiz ◽

Monserrat Muñoz ◽

Ana Balil ◽

Jesús García-Mata ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Research Group ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Phase Iii ◽

Previously Treated

Download Full-text

PO34 FUNDING PRIORITIES FOR CANCER RESEARCH IN USA – AN ADVOCACY INITIATIVE TO GAUGE PERCEPTION OF METASTATIC BREAST CANCER RESEARCH AND FUNDING AMONGST CANCER RESEARCHERS IN THE USA

10.1016/s0960-9776(13)70047-x ◽

2013 ◽

Vol 22 ◽

pp. S30

Author(s):

Arti Santhanam

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Download Full-text

A Stereoselective Route to Guanacastepene A through a Surprising Epoxidation This work was supported by the National Institutes of Health (CA-28824). S.L. is a US Army breast cancer research program postdoctoral fellow (DAMD-17-99-1-9373). G.B.D. is an NIH postdoctoral fellow (1 F32 NS11150-01). D.S.T. is a Damon Runyon Cancer Research Foundation postdoctoral fellow (DRG-1641). We thank Dr. George Sukenick and Sylvi Rusli (NMR Core Facility, CA-02848) for mass spectral analyses.

Angewandte Chemie International Edition ◽

10.1002/1521-3773(20020617)41:12<2188::aid-anie2188>3.0.co;2-j ◽

2002 ◽

Vol 41 (12) ◽

pp. 2188 ◽

Author(s):

Songnian Lin ◽

Gregory B. Dudley ◽

Derek S. Tan ◽

Samuel J. Danishefsky

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Research Program ◽

National Institutes Of Health ◽

Breast Cancer Research ◽

Postdoctoral Fellow ◽

Spectral Analyses ◽

Us Army ◽

Mass Spectral ◽

Guanacastepene A

Download Full-text

Obstacles, Opportunities and Priorities for Advancing Metastatic Breast Cancer Research

Cancer Research ◽

10.1158/0008-5472.can-17-0232 ◽

2017 ◽

Vol 77 (13) ◽

pp. 3386-3390 ◽

Author(s):

Margaret Flowers ◽

Stephanie Birkey Reffey ◽

Shirley A. Mertz ◽

Marc Hurlbert

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Breast Cancer Research

Download Full-text

Body Weight, Menopausal Hormone Therapy, and Risk of Breast Cancer This work was supported by grant CA14089 from the National Cancer Institute and by grant BC044808 from the Department of Defense Congressionally Directed Breast Cancer Research Program.

Treatment of the Postmenopausal Woman ◽

10.1016/b978-012369443-0/50049-1 ◽

2007 ◽

pp. 569-578

Author(s):

ANNA H. WU ◽

C. LEIGH PEARCE ◽

DARCY V. SPICER ◽

SULGGI LEE ◽

MALCOLM C. PIKE

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Body Weight ◽

Hormone Therapy ◽

Research Program ◽

National Cancer Institute ◽

Department Of Defense ◽

Menopausal Hormone Therapy ◽

Breast Cancer Research

Download Full-text

Efficacy of two times four versus continuous eight cycles of paclitaxel/bevacizumab as first-line chemotherapy in metastatic breast cancer: The Stop&Go study of the Dutch Breast Cancer Research Group (BOOG)

Annals of Oncology ◽

10.1093/annonc/mdx365.009 ◽

2017 ◽

Vol 28 ◽

pp. v78-v79

Author(s):

A. Claessens ◽

M. Bos ◽

S. de Groot ◽

E. van Leeuwen-Stok ◽

M. Lopez-Yurda ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Research Group ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Line Chemotherapy

Download Full-text

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-007-0497-5 ◽

2007 ◽

Vol 61 (3) ◽

pp. 509-514 ◽

Author(s):

Daigo Yamamoto ◽

Satoru Iwase ◽

Kaoru Kitamura ◽

Hiroki Odagiri ◽

Chizuko Yamamoto ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Network ◽

Cancer Research Network

Download Full-text

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3131-3 ◽

2014 ◽

Vol 148 (1) ◽

pp. 99-106 ◽

Author(s):

Kathy D. Miller ◽

Sandra K. Althouse ◽

Lisle Nabell ◽

Hope Rugo ◽

Lisa Carey ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Consortium

Download Full-text

A phase II study of medroxyprogesterone acetate (MPA) in patients (pts) with hormone receptor-negative (HR-) metastatic breast cancer (MBC): Translational Breast Cancer Research Consortium trial 007.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1074 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1074-1074

Author(s):

L. G. Vaughn ◽

L. Li ◽

L. Nabell ◽

H. S. Rugo ◽

L. A. Carey ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Research ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Breast Cancer Research ◽

Research Consortium

Download Full-text